Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 18,722 | 31,816 | 32,547 | 30,758 | 38,319 |
| Depreciation Amortization | 5,539 | 4,290 | 3,734 | 3,775 | 4,706 |
| Income taxes - deferred | -1,817 | -1,198 | -65 | -747 | 815 |
| Accounts receivable | 2,914 | 2,674 | -6,201 | -4,996 | 898 |
| Accounts payable and accrued liabilities | -1,671 | 3,890 | -5,059 | 5,625 | -750 |
| Other Working Capital | -3,200 | -2,357 | -15,866 | 2,955 | 3,779 |
| Other Operating Activity | 14,431 | 1,697 | 15,358 | 2,541 | -7,789 |
| Operating Cash Flow | $34,918 | $40,812 | $24,448 | $39,911 | $39,978 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -45,601 | -3,500 | 7,251 | -21,001 | -6,750 |
| PPE Investments | -4,656 | -8,980 | -14,014 | -9,225 | -1,553 |
| Investing Cash Flow | $-50,257 | $-12,480 | $-6,763 | $-30,226 | $-8,303 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,886 | 314 | 1,007 | 1,074 | 2,055 |
| Common Stock Repurchased | -30,000 | N/A | -25,000 | N/A | N/A |
| Other Financing Activity | -1,790 | 0 | 0 | 0 | 3,277 |
| Financing Cash Flow | $-28,904 | $314 | $-23,993 | $1,074 | $5,332 |
| Exchange Rate Effect | 29 | 349 | -138 | -208 | -184 |
| Beginning Cash Position | 133,256 | 104,261 | 110,707 | 100,156 | 63,333 |
| End Cash Position | 89,042 | 133,256 | 104,261 | 110,707 | 100,156 |
| Net Cash Flow | $-44,214 | $28,995 | $-6,446 | $10,551 | $36,823 |
| Free Cash Flow | |||||
| Operating Cash Flow | 34,918 | 40,812 | 24,448 | 39,911 | 39,978 |
| Capital Expenditure | -4,656 | -8,980 | -14,014 | -9,225 | -1,553 |
| Free Cash Flow | 30,262 | 31,832 | 10,434 | 30,686 | 38,425 |